References
- Kannan K, Munirajan AK, Krishnamurthy J, Bhuvarahamurthy V, Mohanprasad BK, Panishankar KH, et al. The p16INK4alpha/p19ARF gene mutations are infrequent and are mutually exclusive to p53 mutations in Indian oral squamous cell carcinomas. Int J Oncol 2000; 16: 585–90
- Liggett WHJ, Sidransky D. Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 1998; 16: 1197–206
- Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1998; 1378: 115–77
- Zhou X, Tarmin L, Yin J, Jiang HJ, Suzuki H, Rhyu MG, et al. The MTS1 gene is frequently mutated in primary human oesophageal tumors. Oncogene 1994; 9: 3737–41
- Shanavaz SA, Bradley G, Regezi JA, Thakker N, Gao L, Hogg D, et al. Patterns of CDKN2A gene loss in sequential oral epithelial dysplasias and carcinomas. Cancer Res 2001; 61: 2371–5
- Riese U, Dahse R, Fiedler W, Theuer C, Koscielny S, Ernst G, et al. Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancer. Mol Med 1999; 4: 61–5
- Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, et al. Germline p16 mutations in familial melanoma. Nat Genet 1994; 8: 15–21
- Gulley ML, Nicholls JM, Schneider BG, Amin MB, Ro JY, Geradts J. Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product. Am J Pathol 1998; 152: 865–9
- Olshan AF, Weissler MC, Pei H, Conway K, Anderson S, Fried DB, et al. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Oncogene 1997; 14: 811–18
- Walker GJ, Hussussian CJ, Flores JF, Glendening JM, Haluska FG, Dracopoli NC, et al. Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds. Hum Mol Genet 1995; 4: 1845–52
- Heidenreich A, Gaddipati JP, Moul JW, Srivastava S. Molecular analysis of p16(INK4)/CDKN2 and p15(INK4B)/MTS2 genes in primary human testicular germ cell tumors. J Urol 1998; 159: 1725–30
- Ranade K, Hussussian CJ, Sikorski RS, Varmus HE, Goldstein AM, Tucker MA, et al. Mutations associated with familial melanoma impair p16INK4 function. Nat Genet 1995; 10: 114–16
- Zhang SY, Lein-Szanto AJP, Sauter ER, Shafarenko M, Mitsunaga S, Nobori T, et al. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumours of the head and neck. Cancer Res 1994; 54: 5050–3
- Dawson CD, Chang KW, Solt DB. MTS 1 gene mutations in archival oral squamous cell carcinomas. J Oral Pathol Med 1996; 25: 541–6
- Gonzales MV, Pello MF, Lopez-Larrea C, Suarez C, Memendez MJ, Coto E. Loss of heterozygocity and mutation analysis of the p16 (9p21) and p53 genes in squamous cell carcinoma of the head and neck. Clin Cancer Res 1995; 1: 1043–9
- Papadimitrakopoulou V, Izzo J, Lippmann SM, Lee JS, Fan YH, Clayman G, et al. Frequent inactivation of p16(INK4a) in oral premalignant lesions. Oncogene 1997; 14: 1799–803
- Sakata K. Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma. Oral Pathol Med 1996; 25: 302–7